8-K filing — ChronoScale Holdings Corp (CHRN)
Filed: 2026-10-15 AccNo: 0001493152-26-047278 Size: 373 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Northland Capital Markets Initiates Coverage On ChronoScale Holdings with Outperform Rating, Announces Price Target of $32
Northland Capital Markets analyst Nehal Chokshi initiates coverage on ChronoScale Holdings (NASDAQ:CHRN) with a Outperform rating and announces Price Target of $32.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Reported October 14: ChronoScale Q1 EPS $(0.18) Misses $(0.09) Estimate, Sales $41.482M Beat $18.100M Estimate
ChronoScale Expands AI Pipeline With $1 Billion Revenue Run Rate In Sight
ChronoScale AI contracts support a $1 billion annualized revenue run rate by Q3 2027 as the company completes its Ekso sale.
Reported Earlier, ChronoScale Holdings Subsidiary Sells Ekso Bionics To Wandercraft In Simultaneously Signed And Closed Deal Approved Unanimously By Both Boards